BECTON DICKINSON MEDICAL SYSTEMS 5 ML BD¿ PRE-FILLED NORMAL SALINE SYRINGE, IN 10 ML SYRINGE; PREFILLED SALINE FLUSH SYRINGE
|
Back to Search Results |
|
Catalog Number 306502 |
Device Problem
Nonstandard Device (1420)
|
Patient Problem
Unspecified Infection (1930)
|
Event Date 05/22/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that a patient contacted an infection after having his appendix removed.The patient had to have a drainage tube placed.The patient indicated that 5 ml bd¿ pre-filled normal saline syringes, in 10 ml syringe were used.Out of an abundance of caution and in the interest of public health, bd voluntarily recalled certain lots of bd posiflush¿ heparin lock flush and bd¿ pre-filled normal saline flush syringes due to a potential for contamination with serratia marcescens bacterium.Bd was notified by the u.S.Food and drug administration (fda) and centers for disease control and prevention (cdc) about a potential epidemiological link between catheter related blood stream infections and the s.Marcescens bacterium.Specifically, the fda and cdc identified a potential connection between reports of infection in a small number of patients caused by s.Marcescens across multiple states.Cdc¿s initial investigation found that affected patients had received treatment using certain bd flush products.To date, there is no evidence of bd flush product testing positive for this bacterium.Investigations are ongoing by bd, fda, and cdc.
|
|
Event Description
|
It was reported that a patient contacted an infection after having his appendix removed.The patient had to have a drainage tube placed.The patient indicated that 5 ml bd¿ pre-filled normal saline syringes, in 10 ml syringe were used.Out of an abundance of caution and in the interest of public health, bd voluntarily recalled certain lots of bd posiflush¿ heparin lock flush and bd¿ pre-filled normal saline flush syringes due to a potential for contamination with serratia marcescens bacterium.Bd was notified by the u.S.Food and drug administration (fda) and centers for disease control and prevention (cdc) about a potential epidemiological link between catheter related blood stream infections and the s.Marcescens bacterium.Specifically, the fda and cdc identified a potential connection between reports of infection in a small number of patients caused by s.Marcescens across multiple states.Cdc¿s initial investigation found that affected patients had received treatment using certain bd flush products.To date, there is no evidence of bd flush product testing positive for this bacterium.Investigations are ongoing by bd, fda, and cdc.
|
|
Manufacturer Narrative
|
Investigation summary: prior to the report of infection evaluated in (b)(4), there was no trend for infection cases reported for franklin product.This complaint is part of a new trend which began in april 2018.Capa: 350041 was initiated to address this issue.100% of retained samples (b)(4) units) were visually inspected.No growth was seen (i.E., solution was clear).Lot: 712411b was manufactured between lots: 705311b and 716192n, both of which exhibited no growth during the confirmatory sterility testing.This, in combination with the daily environmental monitoring and original sterility testing for the lot release, provides confidence in the sterility of the complaint lot.A review of all lot sterility testing performed for product released between april 2015 & june 2018 confirmed that no organism growth was identified for any lots released during the shelf life of this product.A review of the dhr and supporting documentation for lot: 712411b was performed.There were no deviations or non-conformances or out of specifications related to the manufacture of lot: 712411b or the raw materials used to manufacture this lot.Investigation conclusion: the root cause analysis of the reported infection cases under capa: 350041 has not identified a direct causation between the infections and the bd franklin product.Capa: 350041 has been initiated for this issue.
|
|
Search Alerts/Recalls
|
|
|